USTR to Launch Section 301 Probes on Major Partners, Drug Pricing
The U.S. Trade Representative's office will initiate multiple Section 301 investigations targeting major trading partners over issues including drug pricing and discrimination against American tech firms. USTR Jamieson Greer announced the probes Friday, following President Donald Trump's directive after a Supreme Court ruling.